Search results
Colorado Is Trying to Cap a Drug’s Price. Big Pharma Has Other Plans
Rolling Stone via Yahoo News· 2 months agoA state board in Colorado is working to make history by becoming the first in the country to cap the...
Amgen first-quarter profit dips 1%, revenue rises 22%
Reuters via Yahoo News· 1 hour ago(Reuters) -Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating...
20 prescription drugs on Colorado’s affordability radar
KDVR Denver via Yahoo News· 1 month agoDENVER (KDVR) — The Colorado board created to review prescription drug prices is headed to court...
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Zacks via Yahoo Finance· 2 years agoNovartis NVS has announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the...
Rheumatoid Arthritis Treatment: A Guide to Symptom Management
Verywell Health via Yahoo News· 5 months agoTreatment goals for rheumatoid arthritis (RA) are to reduce pain and inflammation and prevent...
Is There a Permanent Cure for Rheumatoid Arthritis?
Verywell Health via Yahoo News· 2 years agoRheumatoid arthritis (RA) is a chronic inflammatory disease that affects many joints, mainly the small joints of the hands and feet. RA occurs when the...
Medicare can now negotiate prices on these drugs to help seniors save
Newsy via AOL· 8 months agoThe exterior of Pfizer in Groton, Conn. The Biden administration announced the first 10 drugs...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 8 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
Reuters via Yahoo Finance· 2 years ago(Reuters) -Amgen Inc on Thursday agreed to buy ChemoCentryx Inc for $3.7 billion to gain access to a...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 2 weeks agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...